** Shares of Beauty Health Company SKIN.O , which makes
HydraFacial skin treatment devices, slides 8.7% to $10.32,
hitting lowest level in nearly six months
** Co revises FY22 EBITDA forecast to $45 mln-$50 mln vs
prior estimate of $50 mln; says forecast hit by stronger dollar
and China's persistent zero-COVID policy
** Co however raises FY22 net sales forecast on continued
demand momentum; now sees net sales of $360 mln-$365 mln, vs
previous range of $340 mln-$350 mln
** Co also reports adj. earnings of 5 cents/shr, beating
analysts' estimates of 2 cents/shr as per Refinitiv IBES data
** Co has beat EPS estimates for four out of eight quarters
** Up to Monday's close, stock had fallen 53.2% YTD
(Reporting by Shristi Achar A in Bengaluru)
((Shristi.AcharA@thomsonreuters.com;))